Patient characteristics and outcomes among acute ischemic stroke patients undergoing intra-arterial therapy (n=73)
| Characteristic | |
|---|---|
| General | |
| Age (years) (mean (SD)) | 67.2 (15.7) |
| Female (n (%)) | 41 (56.2) |
| NIHSS (median (IQR)) | 15.5 (13–19) |
| IV tPA (n (%)) | 44 (60.3) |
| Medical history (n (%)) | |
| HTN | 50 (68.5) |
| DM | 11 (22.9) |
| CAD | 17 (23.3) |
| HLD | 35 (48.0) |
| Atrial fibrillation | 18 (24.7) |
| Warfarin use | 6 (8.3) |
| Aspirin use | 28 (38.9) |
| Statin use | 27 (37.0) |
| Antihypertensive agent use | 49 (67.1) |
| Hyperglycemic agent use | 13 (17.8) |
| Tobacco | 21 (29.2) |
| Laboratory profile | |
| INR (mean (SD)) | 1.14±0.23 |
| Glucose (mean (SD)) | 138±45.2 |
| Imaging characteristics | |
| Good collaterals (n (%)) | 31 (40) |
| LAv (mL) (median (IQR)) | 7.24 (2.2–8.8) |
| DWIv (mL) (median (IQR)) | 15.39 (9.22–20.33) |
| Outcomes (n (%)) | |
| Recanalized | 32 (43.8) |
| Mortality | 19 (27.5) |
| mRS score≤2 | 24 (35.8) |
| sICH | 7 (9.6) |
CAD, coronary artery disease; DM, diabetes mellitus; DWIv, diffusion restricted imaging volume; HLD, hyperlipidemia; HTN, hypertension; INR, international normalized ratio; LAv, leukoaraiosis volume; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; sICH, symptomatic intracranial hemorrhage; tPA, tissue plasminogen activator.